Abstract: The present invention provides ISVD polypeptide derivatives capable of binding coagulation Factor IX(a) and Factor X(a) which are highly potent and provide a sufficiently long half-life such to allow for effective subcutaneous—as well as peroral administration. The ISVD polypeptides derivatives disclosed herein are thus suitable for treatment of haemophilia A, haemophilia A with inhibitors and acquired haemophilia A by various routes of administration including subcutaneous and peroral administration.

Abstract: The present invention relates to multispecific procoagulant antibodies capable of binding to coagulation Factor IX (FIX) and/or the activated form thereof Factor IXa (FIXa), and Factor X (FX) and/or the activated form thereof Factor Xa (FXa) and promoting FX activation by FIXa, antibodies binding their epitopes or parts thereof and methods and composition for treating subjects suffering from a coagulopathy such as haemophilia A as well as kits, methods of manufacture and methods of use.

Abstract: An absorbent article for absorption of body fluids, including an absorbent member that includes at least one plant protein based absorbent material obtainable by a method including the steps of i. providing a mixture or suspension including a liquid and a plant protein, wherein the plant protein is insoluble in the liquid, ii. acylating the plant protein by adding an acylating agent thereto, and iii. obtaining the plant protein based absorbent material.

Abstract: The present invention relates to multispecific procoagulant antibodies capable of binding to coagulation Factor IX (FIX) and/or the activated form thereof Factor IXa (FIXa), and Factor X (FX) and/or the activated form thereof Factor Xa (FXa) and promoting FX activation by FIXa, antibodies binding their epitopes or parts thereof and methods and composition for treating subjects suffering from a coagulopathy such as haemophilia A as well as kits, methods of manufacture and methods of use.

Abstract: The present invention relates to improved procoagulant antibodies including bispecific antibodies capable of binding to coagulation Factor IX (FIX) or the activated form thereof Factor IXa (FIXa) and optionally Factor X (FX) and the activated form thereof Factor Xa (FXa) and promoting FX activation by FIXa, antibodies binding their epitopes and methods and composition for treating subjects suffering from a coagulopathy such as haemophilia A.

Abstract: The present invention relates to multispecific procoagulant antibodies capable of binding to coagulation Factor IX (FIX) and/or the activated form thereof Factor IXa (FIXa), and Factor X (FX) and/or the activated form thereof Factor Xa (FXa) and promoting FX activation by FIXa, antibodies binding their epitopes or parts thereof and methods and composition for treating subjects suffering from a coagulopathy such as haemophilia A as well as kits, methods of manufacture and methods of use.

Abstract: The invention relates to a method of producing an extrudate comprising the steps of providing a plant protein and treating said protein with a solution comprising a nitrogen-containing compound. The solution with the nitrogen-containing compound may moreover comprise an anti-oxidative acid. A product, such as a film, obtained by the method is also described. By using the solvent-free method of the invention, polymers with excellent barrier and tensile properties may be produced.

Abstract: The invention relates to a method of producing an extrudate comprising the steps of providing a plant protein and treating said protein with a solution comprising a nitrogen-containing compound. The solution with the nitrogen-containing compound may moreover comprise an anti-oxidative acid. A product, such as a film, obtained by the method is also described. By using the solvent-free method of the invention, polymers with excellent barrier and tensile properties may be produced.

Abstract: A new recombinant protein called Antisecretory Factor (rAF) and homologues and peptide fragments thereof are described. The protein and the homologues and fragments thereof are useful for normalising pathological fluid transport and/or inflammatory reactions in animals including humans. Antibodies against AF or homologues or fragments thereof are described. Nucleic acids coding for the protein or for homologues or fragments thereof are also described as well as vectors and hosts comprising the nucleic acids. The rAF and homologues and fragments thereof could be used for immunodetection, as feed additive for growing animals and as antidiarrheal and drugs against diseases involving edema, dehydration and/or inflammation.

Abstract: A new recombinant protein called Antisecretory Factor (rAF) and homologues and peptide fragments thereof are described. The protein and the homologues and fragments thereof are useful for normalizing pathological fluid transport and/or inflammatory reactions in animals including humans. Antibodics against AF or homologues or fragments thereof are described. Nucleic acids coding for the protein or for homologues or fragments thereof are also described as well as vectors and hosts comprising the nucleic acids. The rAF and homologues and fragments thereof could be used for immunodetection, as feed additive for growing animals and as antidiarrheal and drugs against diseases involving edema, dehydration and/or inflammation.

Abstract: A material for tissue separation at healing processes in injured soft tissue in mammals including man is described. The material consists of a porous flexible sheet of a protein-free bioresorbable polymer. Processes for preparation of the material and use thereof are also described.

Abstract: Piece of material for an article of clothing (2) and use of the piece of material for production of a garment. The article of clothing is intended to cover at least the upper body and is provided with a front and a back which are finished with a lower edge, a shoulder section with a neck opening (13) and arms. The piece of material (1) has a first edge (3) which is intended to form the lower edge, a second edge (4, 5) opposite this, two side edges (6, 10 and 7, 11) opposite each other and two cuts (8, 9) which extend inwards from the side edges and which are finished at a distance from each other which corresponds approximately to the size across the chest. The piece of material is symmetrical about a center axis (16) on which the neck opening is located, the cuts (8, 9) form an angle, to the center axis (16), which, measured in the direction of the first edge (3), is less than 90.degree..